Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated:  5/23/2016
The Mayo Clinic
mi
from
Rochester, MN
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated: 5/23/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated:  5/23/2016
Fairview Medical-Rosemount
mi
from
Rosemount, MN
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated: 5/23/2016
Fairview Medical-Rosemount
mi
from
Rosemount, MN
Click here to add this to my saved trials
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated:  5/23/2016
Baldwin Area Medical Center, Inc.
mi
from
Baldwin, WI
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated: 5/23/2016
Baldwin Area Medical Center, Inc.
mi
from
Baldwin, WI
Click here to add this to my saved trials
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated:  5/23/2016
Hudson Physicians S.C.
mi
from
Hudson, WI
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated: 5/23/2016
Hudson Physicians S.C.
mi
from
Hudson, WI
Click here to add this to my saved trials
Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning
Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning
Status: Enrolling
Updated:  5/23/2016
New York State Psychiatric Institute
mi
from
New York, NY
Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning
Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning
Status: Enrolling
Updated: 5/23/2016
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Comparative Effectiveness Research for Eliminating Disparities
UPR-CHA Research Center of Excellence- Supplement
Status: Enrolling
Updated:  6/2/2016
Cambridge Health Alliance
mi
from
Somerville, MA
Comparative Effectiveness Research for Eliminating Disparities
UPR-CHA Research Center of Excellence- Supplement
Status: Enrolling
Updated: 6/2/2016
Cambridge Health Alliance
mi
from
Somerville, MA
Click here to add this to my saved trials
Comparative Effectiveness Research for Eliminating Disparities
UPR-CHA Research Center of Excellence- Supplement
Status: Enrolling
Updated:  6/2/2016
Univ of Puerto Rico
mi
from
San Juan,
Comparative Effectiveness Research for Eliminating Disparities
UPR-CHA Research Center of Excellence- Supplement
Status: Enrolling
Updated: 6/2/2016
Univ of Puerto Rico
mi
from
San Juan,
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US012
mi
from
Arcadia, CA
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US012
mi
from
Arcadia, CA
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US004
mi
from
Miami, FL
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US004
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US007
mi
from
Orlando, FL
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US007
mi
from
Orlando, FL
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US013
mi
from
West Palm Beach, FL
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US013
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US006
mi
from
Smyrna, GA
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US006
mi
from
Smyrna, GA
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US002
mi
from
O'Fallon, MO
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US002
mi
from
O'Fallon, MO
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US010
mi
from
Toms River, NJ
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US010
mi
from
Toms River, NJ
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US005
mi
from
New York, NY
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US005
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US008
mi
from
New York, NY
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US008
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US003
mi
from
Staten Island, NY
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US003
mi
from
Staten Island, NY
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US014
mi
from
Oklahoma City, OK
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US014
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US009
mi
from
Allentown, PA
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US009
mi
from
Allentown, PA
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US001
mi
from
Memphis, TN
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US001
mi
from
Memphis, TN
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
US011
mi
from
San Antonio, TX
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
US011
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated:  6/6/2016
EE002
mi
from
Tallinn,
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Status: Enrolling
Updated: 6/6/2016
EE002
mi
from
Tallinn,
Click here to add this to my saved trials
Neurobiological Bases of Placebo Response in Major Depressive Disorder
Neurobiological Bases of Placebo Response in Major Depressive Disorder
Status: Enrolling
Updated:  6/13/2016
Massachusetts General Hospital- Depression Clinical and Research Program
mi
from
Boston, MA
Neurobiological Bases of Placebo Response in Major Depressive Disorder
Neurobiological Bases of Placebo Response in Major Depressive Disorder
Status: Enrolling
Updated: 6/13/2016
Massachusetts General Hospital- Depression Clinical and Research Program
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 109
mi
from
Imperial, CA
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 109
mi
from
Imperial, CA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative site 049
mi
from
Los Angeles, CA
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative site 049
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 023
mi
from
Murrieta, CA
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 023
mi
from
Murrieta, CA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 009
mi
from
Orange, CA
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 009
mi
from
Orange, CA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 007
mi
from
San Diego, CA
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 007
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 008
mi
from
Washington,
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 008
mi
from
Washington,
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 064
mi
from
Gainesville, FL
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 064
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 08
mi
from
Jacksonville Beach, FL
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 08
mi
from
Jacksonville Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative site 067
mi
from
Miami, FL
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative site 067
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 085
mi
from
Oakland Park, FL
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 085
mi
from
Oakland Park, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 061
mi
from
Orlando, FL
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 061
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 061
mi
from
Orlando, FL
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 061
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site
mi
from
Atlanta, GA
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 1735
mi
from
Roswell, GA
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 1735
mi
from
Roswell, GA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 032
mi
from
Libertyville, IL
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 032
mi
from
Libertyville, IL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 023
mi
from
Naperville, IL
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 023
mi
from
Naperville, IL
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 051
mi
from
Terre Haute, IN
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 051
mi
from
Terre Haute, IN
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 004
mi
from
Overland Park, KA
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 004
mi
from
Overland Park, KA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 006
mi
from
Lake Charles, LA
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 006
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site
mi
from
Baltimore, MD
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site
mi
from
Baltimore, MD
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 006
mi
from
Rockville, MD
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 006
mi
from
Rockville, MD
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 026
mi
from
Watertown, MA
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 026
mi
from
Watertown, MA
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 28
mi
from
Rochester Hills, MI
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 28
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 022
mi
from
Creve Coeur, MO
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 022
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 012
mi
from
Las Vegas, NV
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 012
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated:  6/15/2016
Forest Investigative Site 023
mi
from
Cherry Hill, NJ
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status: Enrolling
Updated: 6/15/2016
Forest Investigative Site 023
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials